BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 21209038)

  • 21. The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer.
    Yang L; Zhang W; Chopra S; Kaur D; Wang H; Li M; Chen P; Zhang W
    Curr Drug Targets; 2020; 21(11):1099-1104. PubMed ID: 32364072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.
    Fang MZ; Chen D; Sun Y; Jin Z; Christman JK; Yang CS
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7033-41. PubMed ID: 16203797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
    Balasubramanian S; Adhikary G; Eckert RL
    Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.
    Egger G; Aparicio AM; Escobar SG; Jones PA
    Cancer Res; 2007 Jan; 67(1):346-53. PubMed ID: 17210717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA demethylation is superior to histone acetylation for reactivating cancer-associated genes in ovarian cancer cells.
    Meng CF; Su B; Li W
    Mol Med Rep; 2011; 4(6):1273-8. PubMed ID: 21850374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation.
    Richon VM; Sandhoff TW; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10014-9. PubMed ID: 10954755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Nihal M; Ahmad N; Mukhtar H; Wood GS
    Int J Cancer; 2005 Apr; 114(4):513-21. PubMed ID: 15609335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long term transcriptional reactivation of epigenetically silenced genes in colorectal cancer cells requires DNA hypomethylation and histone acetylation.
    Mossman D; Scott RJ
    PLoS One; 2011; 6(8):e23127. PubMed ID: 21829702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival.
    Balasubramanian S; Scharadin TM; Han B; Xu W; Eckert RL
    Cell Signal; 2015 Jul; 27(7):1336-44. PubMed ID: 25843776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification.
    Majid S; Kikuno N; Nelles J; Noonan E; Tanaka Y; Kawamoto K; Hirata H; Li LC; Zhao H; Okino ST; Place RF; Pookot D; Dahiya R
    Cancer Res; 2008 Apr; 68(8):2736-44. PubMed ID: 18413741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
    Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
    Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure.
    Yan Y; Kluz T; Zhang P; Chen HB; Costa M
    Toxicol Appl Pharmacol; 2003 Aug; 190(3):272-7. PubMed ID: 12902198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor suppressor genes p21 and p16 in a Tet-dependent DNA demethylation manner in human skin cancer cells.
    Lin JR; Qin HH; Wu WY; He SJ; Xu JH
    Cancer Biother Radiopharm; 2014 Aug; 29(6):257-64. PubMed ID: 25003799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
    Stimson KM; Vertino PM
    J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.
    Zhu X; Mao X; Hurren R; Schimmer AD; Ezzat S; Asa SL
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3610-7. PubMed ID: 18544619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Green tea polyphenol epigallocatechin 3-gallate, contributes to the degradation of DNMT3A and HDAC3 in HCT 116 human colon cancer cells.
    Moseley VR; Morris J; Knackstedt RW; Wargovich MJ
    Anticancer Res; 2013 Dec; 33(12):5325-33. PubMed ID: 24324066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.